Supreme Court: Ad Valorem Court Fees Apply to Appeals Seeking Statutory Land Acquisition Benefits  ||  Supreme Court: Cruise Voyages Remain Shipping Business under Section 44B Despite Onboard Services  ||  Supreme Court: People Abandon Cattle on Roads But Object to Their Use For Food  ||  Supreme Court Stays CIC Decision Declaring NSE Subject to the RTI Act  ||  SC: Wife May Be Denied Interim Maintenance if Husband Ex Facie Establishes Adultery  ||  SC: Prior Testimony is Inadmissible without Section 299 CrPC Order against Absconder  ||  Supreme Court: Administrative Action Can't Be Invalidated Solely for Lacking Formal Order  ||  Calcutta High Court: Section 141 NI Act Does Not Apply to Sole Proprietorships  ||  Orissa High Court Criticizes Magistrate for Defying Direction in Cheque Bounce Case  ||  Delhi High Court Safeguards Yuvraj Singh's Personality Rights, Orders Deepfake Takedown    

Competition Commission of India Levies Rs 74 Cr Fine on Himalaya Drug and Three Others - (05 Jun 2019)

MRTP/ COMPETITION LAWS

Competition Commission of India has imposed a total fine of over Rs 74 crore on Himalaya Drug Company and Intas Pharmaceuticals along with its senior officials as well as two Madhya Pradesh-based drug groupings namely Madhya Pradesh Chemists and Druggist Association and Indore Chemists Association for indulging in anti-competitive trade practices.

Tags : COMPETITION COMMISSION OF INDIA   HIMALAYA DRUG  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved